I like this from the article - “Based on our
Post# of 148292
(Total Views: 498)
Posted On: 11/22/2021 9:42:53 AM
Re: Buddyboy20 #110833
I like this from the article -
Leronlimab can do both.
Quote:
“Based on our observations, there is evidence that an inhibitor of nanotube formation could be combined with cancer immunotherapies and tested to see if it can improve outcomes for patients.”
Leronlimab can do both.
(13)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼